Roka Bioscience (ROKA) Reports Q2 Loss of $0.43

August 5, 2016 8:10 AM EDT
Get Alerts ROKA Hot Sheet
Trade ROKA Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Roka Bioscience (NASDAQ: ROKA) reported Q2 EPS of ($0.43), versus ($0.54) reported last year. Revenue for the quarter came in at $1.82 million, versus $1.47 million reported last year.

For earnings history and earnings-related data on Roka Bioscience (ROKA) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment